Max Healthcare Institute Limited — Dividend/Bonus, 20-05-2025: Dividend

Max Healthcare has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue stood at ₹7,028 Cr with a profit after tax of ₹1,076 Cr for the year. Earnings per share were ₹11.07 (consolidated) and ₹7.21 (standalone) annualised.

The board declared a final dividend of ₹1.50 per share (15% of face value) from FY25 profits, pending shareholder approval, payable within 30 days of the AGM.

Key highlights include a ~100-bed expansion at Max Super Speciality Hospital, Nagpur, with a ₹118 Cr investment funded by internal accruals and a ₹100 Cr loan. New statutory auditors to be appointed, subject to approval.

Stable profitability and growth plans bode well for shareholders.